Navigation Links
Ovarian Tumors May Develop Years After Fertility Therapy
Date:10/27/2011

y population to examine that issue.

"If we find out that women who receive several IVF cycles or large doses of ovarian-stimulating drugs are at a greater risk of ovarian cancer, then these women would need to be informed about these risks when continuing IVF treatment and possibly advised to discontinue treatment after three to six cycles (depending on which number of cycles would be associated with the high risk of ovarian malignancies)," van Leeuwen noted.

The International Federation of Fertility Societies (IFFS) issued a statement in response to the new study findings. In it, general secretary of the IFFS, Richard Kennedy of Coventry, England, said: "Over the last decade, several reports have considered the long-term risks of ovarian stimulation practiced as part of the IVF process. These reports have been generally reassuring in terms of risk of ovarian cancer."

However, Kennedy added, "This new research has highlighted the presence of an increased risk of borderline tumors . . . and has once again posed a question about the long-term risks of ovarian stimulation further confounded by the known underlying risks for these patients. The IFFS remains of the view that the long-term risks are low but calls for continued vigilance through reporting of long-term outcomes with international collaboration."

More information

The American Cancer Society has more about ovarian cancer.

-- Robert Preidt

SOURCES: Human Reproduction, news release, Oct. 26, 2011; International Federation of Fertility Societies, statement, Oct. 26, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Linking of mutations in 12 genes to ovarian cancer may lead to more effective prevention
2. Terry Fox Research Institute aims to change diagnosis and management of ovarian cancer worldwide
3. Mutant Gene That Ups Risk for Ovarian Cancer May Aid Survival
4. Early detection is key in the fight against ovarian cancer
5. Moffitt researchers find possible key to preventing chemotherapy resistance in ovarian cancer
6. New hybrid imaging device shows promise in spotting hard-to-detect ovarian cancer
7. FDA clears biomarker test for ovarian cancer
8. Key function of mutation in hereditary breast and ovarian cancer gene discovered
9. Plants could pave the way for new ovarian cancer treatments
10. Trial Drug Shows Preliminary Promise Against Ovarian Cancer
11. Blood Antibody May Signal Start of Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Ovarian Tumors May Develop Years After Fertility Therapy
(Date:3/26/2015)... York (PRWEB) March 26, 2015 ... move forward nationwide, with the issuance of new ... Pennsylvania and Louisiana. According to an Order dated ... litigation established for Xarelto injury claims in the ... now allow plaintiffs to file cases directly in ...
(Date:3/26/2015)... March 26, 2015 “The SWEET Act is ... healthy options more available and help parents who are working ... is a reasonable approach to support public health, and we ... issue for the health of all families,” said Dr. Jane ... Health on the introduction of the Sugar-Sweetened Beverage Tax (SWEET) ...
(Date:3/26/2015)... CA (PRWEB) March 26, 2015 Dr. ... are proud to announce expanded offerings for Bay Area ... Francisco Dental Implant Center has long been a top-rated ... expanded its offerings to meet the strong demand by ... our reputation as a top-rated dental implant facility in ...
(Date:3/26/2015)... Altamonte Springs, FL (PRWEB) March 26, 2015 ... one of the nation’s leading innovative specialty pharmacies, ... newly created position of Vice President of Pharmaceutical ... for fostering beneficial connections with our pharmaceuticals partners ... pharmaceutical relationships in support of BioPlus’ expansion. ...
(Date:3/26/2015)... London, UK (PRWEB) March 26, 2015 In ... 40 billion as of 2013 and is set to decrease ... billion by 2020; the growth is expected up to 2017 ... growth is expected to be owing to the surging penetration ... Tekturna HCT, Twynsta, Micardis Plus, Valturna, Benicar HCT, and Tekamlo), ...
Breaking Medicine News(10 mins):Health News:Xarelto Lawsuits Move Forward Nationwide, With Issuance of New Court Docs in State, Federal Litigations 2Health News:Xarelto Lawsuits Move Forward Nationwide, With Issuance of New Court Docs in State, Federal Litigations 3Health News:National Alliance for Hispanic Health Statement on Introduction of SWEET Act in 114th Congress 2Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 2Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 3Health News:BioPlus Specialty Pharmacy Expands Executive Team with New Position, Naming Sharon Ferrer as Vice President of Pharmaceutical Relations 2Health News:Top 8 Developed Anti-Hypertensive Therapeutics Markets Discussed in New GBI Research Report Published at MarketPublishers.com 2Health News:Top 8 Developed Anti-Hypertensive Therapeutics Markets Discussed in New GBI Research Report Published at MarketPublishers.com 3
... 81-year-old San Francisco woman with dementia, little money and an equally aged ... A 72-year-old Riverside woman with Alzheimer,s who cannot be left safely on ... care for her. A 78-year-old Los Angeles ... take care of him if day care services are cut. ...
... Angeles, London, New Delhi, Singapore and Washington DC (October ... with diabetes to modify their behavior, adjust their medicine ... to a recent study, published by SAGE in ... testing," a self-monitored testing both before and after specific ...
... remains a mystery, , THURSDAY, Oct. 1 (HealthDay News) -- ... still in their mother,s womb were about 20 percent more ... study has found. , The flu outbreak in 1918 killed ... the United States. That flu, like the current H1N1 swine ...
... ... to maximize cell culture media performance and will be on display at BioProcess International ... in Raleigh, North Carolina. , ... Fort Collins, CO (PRWEB) October 1, 2009 -- As conference exhibitor and ...
... The 2nd ... in New York, NY. This three-day conference will explore address all aspects of signal detection ... ... The 2nd DIA Conference on Signal Detection and Data Mining will be held ...
... Support for Addressing Crisis of Chronic Disease , ... are voicing their support for health reform that prioritizes ... to Health Reform" ( www.sayyestohealthreform.com ) - an ... (PFCD) directed at Congressional leaders in Washington. , The campaign ...
Cached Medicine News:Health News:Half-million low-income elderly affected by sweeping cuts to state safety net 2Health News:Half-million low-income elderly affected by sweeping cuts to state safety net 3Health News:Pre-Birth Exposure to 1918 Flu Raised Heart Risks, Study Finds 2Health News:Pre-Birth Exposure to 1918 Flu Raised Heart Risks, Study Finds 3Health News:InVitria's Better Ingredients for Better Media to be Showcased at BPI '09 2Health News:International Experts to Review State-of-the-Art Thinking on Signal Detection and Data Mining 2Health News:International Experts to Review State-of-the-Art Thinking on Signal Detection and Data Mining 3Health News:Maryland Residents Participate in Launch of National Video Campaign: 'Say 'Yes' to Health Reform' 2Health News:Maryland Residents Participate in Launch of National Video Campaign: 'Say 'Yes' to Health Reform' 3
(Date:3/26/2015)... Calif. , March 26, 2015  Desert Valley ... Nation five times , is the first U.S. ... in its emergency department to help clinicians prevent hospital ... Victorville, Calif. , is a community ... bariatric patients.  Using the Leaf Patient Monitor in the ...
(Date:3/26/2015)... , March 26, 2015  The inaugural ... the use of health technology innovations that improve ... foster collaborations to improve development and adoption of ... the structures and processes within delivery systems that ... providers, investors, entrepreneurs, developers and other stakeholders, takes ...
(Date:3/26/2015)... InfuSystem Holdings, Inc. (NYSE MKT: INFU), a leading ... healthcare industry in the United States ... secured a new $45.0 million credit facility with JPMorgan Chase ... facility with its prior lender group.  Effective ... senior secured credit agreement comprised of a $10.0 million asset-based ...
Breaking Medicine Technology:Desert Valley Medical Center First to Use Leaf Healthcare Patient Wearable Technology in its ED as Part of Hospital-wide Deployment 2Desert Valley Medical Center First to Use Leaf Healthcare Patient Wearable Technology in its ED as Part of Hospital-wide Deployment 3HX360 To Highlight New, Innovative Technology-Based Solutions To Improve Care Coordination, Workflow, Patient Experience 2HX360 To Highlight New, Innovative Technology-Based Solutions To Improve Care Coordination, Workflow, Patient Experience 3HX360 To Highlight New, Innovative Technology-Based Solutions To Improve Care Coordination, Workflow, Patient Experience 4InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 2InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 3InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 4
... -- Micell,Technologies announced today that the Company ... supercritical fluid (SCF) surface modification,technology for drug-eluting ... Annual Meeting, April 19-21 2007 in Chicago,Illinois. ... and PNNL's, 2006 R&D,100 Award winning e-RESS ...
... and CARLSBAD, Calif., April 18, 2007,/PRNewswire-FirstCall/ -- ... from a preclinical study in which BiTE(R) ... prevent,subcutaneous tumor growth and formation of lung ... is frequently,expressed on breast, colon and other ...
Cached Medicine Technology:Micell Technologies Presents Data on Novel Drug-Eluting Stents 2Micell Technologies Presents Data on Novel Drug-Eluting Stents 3Micromet and MedImmune Present Data From Preclinical Study of New,BiTE Molecule Targeting CEA 2Micromet and MedImmune Present Data From Preclinical Study of New,BiTE Molecule Targeting CEA 3Micromet and MedImmune Present Data From Preclinical Study of New,BiTE Molecule Targeting CEA 4Micromet and MedImmune Present Data From Preclinical Study of New,BiTE Molecule Targeting CEA 5
... Conduit TCP is a synthetic porous ceramic ... similar to the mineral phase that comprises 70% ... that provides a scaffold that allows the attachment ... development of vascular networks within granules as well ...
Schuknecht-Weitlaner retractor, sharp, angled arms....
Weitlaner Beckmann retractor, sharp prongs, SS....
Scoville sharp curette, 10, straight, scoop size 4 x 10 mm....
Medicine Products: